Reducing eDiscovery risk for Pharmaceutical Companies

Why Should You Attend:

Pharmaceutical and Biotech companies are often involved with litigation concerned with either contractual issues with business partners or patent and trademark infringement. Adversaries often request documentation they may find relevant to their cases. This has driven the adoption of formal information retention programs and eDiscovery practices. Email is no longer the most commonly requested records companies must produce . Both structured and unstructured information sources have recently outranked email. Notably, too, is the rise in demands for access to social media and mobile phone text messages.

eDiscovery costs can be enormous requiring large investments in IT resources to retrieve requested records and the hiring of specialists to sort through the archives, not to mention advice and guidance from legal consultants.

This session will describe an effective strategy that will minimize the costs associated with litigation and eDiscovery based on records management concepts. The program outlined in this presentation will not only lower litigation costs but will result in increased personal information utilization efficiency and lower IT costs.

Areas Covered in the Seminar:

• Record policy and procedures.
• Disaster recovery versus records preservation.
• Instituting Records Management educational programs.
• Litigation hold – the essentials.
• Isolating, preserving and validating records in litigation hold.
• Methodology and techniques for analyzing records on hold.
• Approaches to handling comingled records.